| Paramount Healthcare | Genetic Testing for Macular Degeneration | 2026-03-06 |
| Paramount Healthcare | Progenitor Cell Therapy for Treatment of Damaged Myocardium | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.01.035 Cresemba (isavuconazonium) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.01.038 Daraprim (pyrimethamine) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.01.042 Anthelmintic Drugs | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.01.048 Arikayce (amikacin liposome inhalation suspension) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.01.050 Aemcolo (rifamycin) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.01.054 Baxdela (delafloxacin) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.01.058 Cabenuva (cabotegravir rilpivirine) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.01.072 Brexafemme (ibrexfungerp) | 2026-03-06 |